Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple MyelomaDavid H. Henry, Howard Yeh, Luís Costa et al.|Journal of Clinical Oncology|2011Cited by 1.3k
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumorsDavid H. Henry, Howard Yeh, Saroj Vadhan‐Raj et al.|Supportive Care in Cancer|2013Cited by 182
Pain outcomes in patients with advanced breast cancer and bone metastasesCharles S. Cleeland, Karen Chung, Donald L. Patrick et al.|Cancer|2012Cited by 155
Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of expertsRoger von Moos, Axel Hauschild, Reinhard Dummer et al.|European Journal of Cancer|2008Cited by 128
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinomaYing Waeckerle‐Men, Silke Gillessen, M. Fopp et al.|Cancer Immunology Immunotherapy|2006Cited by 118